Inhibidores de PARP en primera línea de cáncer de ovario | PPT
Treatment Considerations With Niraparib
Treatment and Maintenance Therapy in Advanced Ovarian Cancer | VuMedi
Efficacy | ZEJULA (niraparib) for HCPs
CME; Niraparib, Olaparib, bevacizumab, PRIMA trial, PAOLO-1
Stephen V Liu, MD on X: "#ESMO19 Practice changing study presented by Antonio Gonzalez Martin. PRIMA study of niraparib in patients with ovarian cancer responding to 1L platinum based chemo. Primary endpoint
The Changing Role of PARP Inhibitors in the Treatment of Ovarian Cancer | PPT
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5) -
Use of First-Line PARP Inhibitors in Ovarian Cancer | Published in healthbook TIMES Oncology Hematology
Personalized Dosing of Niraparib in Ovarian Cancer - YouTube
Predictors of Long-term Progression-Free Survival in Niraparib-Treated Patients in the PRIMA/ENGOT-OV16/GOG-3012 Study
Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - European Journal of
Pivotal Trials in the Realm of Ovarian Cancer
Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context | Future Oncology
Efficacy of niraparib in the PRIMA phase III trial | Download Scientific Diagram
Niraparib Efficacy and Safety in Patients with BRCA-Mutated (BRCAm) Ovarian Cancer: Results from Three Phase 3 Niraparib Trials
Niraparib Prolongs PFS in Patients with Newly Diagnosed Advanced
PRIMA: Frontline Niraparib Maintenance Therapy in Ovarian Cancer
Efficacy of niraparib in the PRIMA trial | Download Scientific Diagram
TESARO Pioneers Summit - ppt download
PARP inhibitors as first-line maintenance treatment for ovarian cancer: Translating the latest data to clinical practice - touchONCOLOGY
